Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell Titan, Page Industries conditional buy: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one may sell Titan Company and feels that Page Industries is a conditional buy.

    • BoAML retains buy on Aurobindo, sees 23% EPS CAGR over FY16-18

      Bank of America Merrill Lynch (BoAML) has maintained its buy rating on Aurobindo Pharma on expectations of strong 23 percent earnings per share (EPS) CAGR over FY16-18, especially after USFDA's successful inspection of unit IV plant at Andhra Pradesh and establishment inspection report for Penem facilities.

    • Buy Aurobindo Pharma, Havells, LIC Housing: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the viwe that one can buy Aurobindo Pharma, Havells India and LIC Housing Finance.

    • Buy, sell or hold: 3 stocks that analysts focus on

      CLSA has a buy rating on Jubilant Foodworks but says the stock will be under pressure in near-term as departure of two key members raises several concerns.

    • Optimistic on Aurobindo Pharma, says Mayuresh Joshi

      Mayuresh Joshi of Angel Broking is optimistic on Aurobindo Pharma.

    • Buy IDBI Bank, IRB Infra, OIL, Aurobindo Pharma: Rakesh Bansal

      Rakesh Bansal of RK Global recommends buying IDBI Bank, IRB Infra, Oil India and Aurobindo Pharma.

    • Buy Amara Raja, Divis Lab; sell Indo Count Industries: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Amara Raja Batteries and Divis Lab and sell Indo Count Industries.

    • Aurobindo Pharma may test Rs 814, Cipla Rs 594: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that Aurobindo Pharma may test Rs 814 while Cipla may hit Rs 594.

    • Buy Lloyd Electric, Tata Motors, Aurobindo Pharma:Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Lloyd Electric, Tata Motors and Aurobindo Pharma.

    • Buy Aurobindo Pharma, Bharat Forge, Vedanta: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, Bharat Forge and Vedanta.

    • Buy Torrent Pharma, Aurobindo; Lupin may hit Rs 1800: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Torrent Pharma and Aurobindo Pharma and feels that Lupin may hit Rs 1800.

    • Buy Yes Bank, Apollo Tyres, PNB; sell HDFC, ITC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Yes Bank, Apollo Tyres, PNB and pharma stocks and advises selling HDFC and ITC.

    • Buy Aurobindo Pharma, IOB; sell Jubilant Food: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com recommends buying Aurobindo Pharma, Torrent Pharma, Indian Overseas Bank and Ashoka Buildcon and advises selling Jubilant Foodworks.

    • Bull's Eye: Buy Cox & Kings, Wockhardt, HDIL, Fortis Healthcare

      Ruchit Jain of Angel Broking recommends buying Cox & Kings with target of Rs 214 and IPCA Labs with target of Rs 604.

    • Buy Aurobindo Pharma, Stride Shasun, Torrent Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Aurobindo Pharma, Stride Shasun and Torrent Pharma.

    • Bull's Eye: Sell DLF, Tata Elxsi, HDIL; buy JBM Auto, Exide

      Jay Thakkar of Sharekhan is of the view that one may buy JBM Auto with a target of Rs 236.10.

    • Buy Sanghi Industries, Axis Bank, Natco Pharma: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can buy Sanghi Industries, Axis Bank and Natco Pharma.

    • Buy L&T, Aurobindo Pharma, HCL Technologies: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Larsen and Toubro, Aurobindo Pharma and HCL Technologies.

    • Strong US pipeline makes Aurobindo Pharma a very good bet: IIFL

      Bhavesh Gandhi of India Infoline expects a strong US pipeline playing out for the company in the injectibles side. With a positive management commentary for FY17, IIFL believes it is the cheapest stock in the frontline large-cap space, he told CNBC-TV18 .

    • Here are a few stock ideas from Mayuresh Joshi

      In an interview to CNBC-TV18, Mayuresh Joshi, Fund Manager (PMS) at Angel Broking Ltd shared his readings and outlook on specific stocks and sectors.

    • Investment tips: Do you have these 4 stocks in your portfolio?

      Deutsche Bank downgraded Axis Bank to hold with target price unchanged at Rs 590 per share. It says ROEs may decline to 14-15 percent while credit costs may be elevated.

    • Buy Aurobindo Pharma, Jain Irrigation, IGL: Rahul Shah

      Rahul Shah of Motilal Oswal Securities recommends buying Aurobindo Pharma, Jain Irrigation Systems and Indraprashtha Gas.

    • Buy Reliance Cap, Aurobindo Pharma, AB Nuvo: Sandeep Wagle

      Sandeep Wagle of powermywealth.com recommends buying Reliance Capital, Aurobindo Pharma and Aditya Birla Nuvo.

    • Buy Aurobindo Pharma, Oil India; sell L&T: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can buy Aurobindo Pharma, Oil India and sell L&T.

    • Buy Aurobindo Pharma, Aarti Industries, Chennai Petro: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, Aarti Industries and Chennai Petroleum Corporation.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347